China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

Market Cap	13.39B
Revenue (ttm)	1.82B
Net Income (ttm)	384.45M
Shares Out	504.25M
EPS (ttm)	0.77
PE Ratio	34.56
Forward PE	23.88
Dividend	0.32 (1.21%)
Ex-Dividend Date	Oct 25, 2024

Volume	3,048,300
Average Volume	11,231,049
Open	26.48
Previous Close	26.60
Day's Range	26.48 - 26.71
52-Week Range	26.28 - 41.98
Beta	0.44
RSI	36.70
Earnings Date	Apr 25, 2025

About SHE:300294

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China. The company offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products. It provides bone polypeptide, oxytocin, heparin sodium, and posterior pituitary injection products; and metformin hydrochloride enteric-coated tablets, glimepiride tablets, calcium dobesilate products, and pioglitazone hydrochloride dispersible ta...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1993
• Employees: 1,938
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300294

Financial Performance

In 2024, SHE:300294's revenue was 1.73 billion, a decrease of -34.58% compared to the previous year's 2.65 billion. Earnings were 396.99 million, an increase of 67.18%.